Geneos Wealth Management’s Calumet Specialty Products CLMT Stock Holding History

Geneos Wealth Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-600	Closed	-$3K	–	2390
2018 Q3	$3K	Buy	600 +300	+100%	+$2.13K	﹤0.01%	2163
2018 Q2	$2K	Sell	300 -600	-67%	-$4.51K	﹤0.01%	2095
2018 Q1	$6K	Sell	900 -1,000	-53%	-$7.39K	﹤0.01%	1804
2017 Q4	$14K	Hold	1,900	–	–	﹤0.01%	1510
2017 Q3	$15K	Buy	1,900 +300	+19%	+$1.87K	﹤0.01%	1429
2017 Q2	$6K	Hold	1,600	–	–	﹤0.01%	1666
2017 Q1	$6K	Hold	1,600	–	–	﹤0.01%	1628
2016 Q4	$6K	Hold	1,600	–	–	﹤0.01%	1562
2016 Q3	$7K	Hold	1,600	–	–	﹤0.01%	1470
2016 Q2	$7K	Hold	1,600	–	–	﹤0.01%	1419
2016 Q1	$17K	Buy	+1,600	New	+$22.3K	﹤0.01%	1134

Other funds holding CLMT

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

SCM

SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WWM

Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

IECM

Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return

Geneos Wealth Management's CLMT Position: Q4 2018 in Review

Geneos Wealth Management sold out of Calumet Specialty Products (CLMT) in Q4 2018, closing a stake of 600 shares — an estimated $3K sold.

Geneos Wealth Management first reported a position in CLMT in Q1 2016 and held it in 11 quarters. The position peaked at $17K in Q1 2016. 64 funds tracked by Wall St. Rank hold CLMT as of Q4 2018.

Geneos Wealth Management reported no remaining Calumet Specialty Products position as of Q4 2018 after selling out during the quarter.
Geneos Wealth Management sold 600 Calumet Specialty Products shares in Q4 2018, an estimated $3K.
Geneos Wealth Management first reported a position in Calumet Specialty Products in Q1 2016 and held it in 11 quarters.
Geneos Wealth Management's Calumet Specialty Products position peaked at $17K in Q1 2016.
64 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2018.

Based on Geneos Wealth Management's 13F filing for Q4 2018, filed 7 Sep 2021.